Enanta Pharmaceuticals (NASDAQ:ENTA) reported its Q3 earnings results on Monday, August 8, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Enanta Pharmaceuticals missed estimated earnings by 10.07%, reporting an EPS of $-1.53 versus an estimate of $-1.39.
Revenue was down $2.15 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.2 which was followed by a 6.52% increase in the share price the next day.
Here's a look at Enanta Pharmaceuticals's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.43 | -1.09 | -1.22 | -1.26 |
| EPS Actual | -1.63 | -1.48 | -1.22 | -1.19 |
| Revenue Estimate | 20.67M | 27.44M | 26.34M | 22.14M |
| Revenue Actual | 18.72M | 27.65M | 23.57M | 21.62M |
To track all earnings releases for Enanta Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
